학술논문
Cariprazine versus risperidone monotherapy for treatment of predominant negative symptoms in patients with schizophrenia: a randomised, double-blind, controlled trial
Document Type
Article
Author
Source
In The Lancet 18-24 March 2017 389(10074):1103-1113
Subject
Language
ISSN
0140-6736